Table of Contents
Leukemia Research and Treatment
Volume 2013, Article ID 238528, 9 pages
http://dx.doi.org/10.1155/2013/238528
Clinical Study

Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies

1Department of Child Health, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
2Department of Pediatrics, University of Tsukuba Hospital, Japan
3Department of Hematology/Oncology, Ibaraki Children’s Hospital, Japan
4Department of Epidemiology, Faculty of Medicine, University of Tsukuba, Japan
5Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Japan
6Department of Genetics, Faculty of Medicine, University of Tsukuba, Japan

Received 24 July 2013; Accepted 10 October 2013

Academic Editor: Massimo Breccia

Copyright © 2013 Hiroko Fukushima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hiroko Fukushima, Takashi Fukushima, Aiko Sakai, et al., “Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies,” Leukemia Research and Treatment, vol. 2013, Article ID 238528, 9 pages, 2013. https://doi.org/10.1155/2013/238528.